Piper Sandler believes that the overall uptrend in markets remains intact, adding that traders and investors should look to buy the dip on pullbacks. Read more here.

Piper Sandler upgraded Campbell (CPB) to Overweight from Neutral with a price target of $56, up from $47. The firm is citing better long-term ...

In a report released today, Allison Bratzel from Piper Sandler maintained a Hold rating on Rigel (RIGL – Research Report), with a price target of $23.00. The company’s shares closed yesterday at ...

Dogecoin shot higher on Tuesday night after President-elect Donald Trump formally announced the creation of the Department of ...

Nvidia (NASDAQ: NVDA) has been the flag bearer for the artificial intelligence (AI) investing revolution since shortly after ...

We recently compiled a list of the 14 AI News You Should Pay Attention To. In this article, we are going to take a look at ...

Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential ...

While tiny, the week’s increase in total application volume marked the first rise in overall demand in seven weeks.

Banks are under pressure to kick criminals off their platforms and compensate more victims as regulators and lawmakers focus ...

OrthoPediatrics Corp. ("OrthoPediatrics” or the "Company”) (Nasdaq: KIDS a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & ...

Fintel reports that on November 11, 2024, Piper Sandler downgraded their outlook for Xeris Biopharma Holdings (NasdaqGS:XERS) ...

EPAM, which follows a January-December fiscal year, closed the September quarter with $1.17 billion in revenue, achieving a ...